Grants and Contributions:
Title:
UKRI Quantum - 10075392 - QD BioSense - Development of a Circulating Tumour Cell Isolation & Detection Point of Care Device
Agreement Number:
1010942
Agreement Value:
$366,500.00
Agreement Date:
Oct 1, 2023 - Dec 31, 2025
Description:
As part of the international UKRI Quantum program consortium project “QD BioSense” (ID number 10075392) which is led by Beyond Blood Diagnostics in the United Kingdom. This project will focus on developing a new generation of simple to use, highly automated and scalable point of care cancer diagnostic system incorporating a microfluidic cytometer with biocompatible silicon quantum dots and high sensitivity camera.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T6N 1H1
Reference Number:
172-2023-2024-Q4-1010942
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
779260892
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days.
Amendment Date
Mar 27, 2025
Recipient's Legal Name:
Applied Quantum Materials Inc.
Federal Riding Name:
Edmonton Mill Woods
Federal Riding Number:
48017
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325189
Amendments: